Supernus Pharmaceuticals (SUPN) Q4 2024 Earnings

4NovConfirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0
0.39
0.78
1.17

Details

Expected EPS
0.443333
Actual EPS
1.168432
Surprise EPS
0.73
Surprise Percent
+163.56%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of 1.168432 per share for Q4 2024.

0 Comments

Share your thoughts